Michael S. Wyzga, Executive VP and CFO at GENZYME CORP (GENZ), sold 29,390 shares at $79.00 ($2.3M) on 2008-08-12, disclosed to the SEC on 2008-08-13.
Open-market sale of $2.3M GENZ by Executive VP and CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| EXAS | SELL | 2019-08-02 | $590K | — | Filing → |
| EXAS | SELL | 2019-03-01 | $48K | — | Filing → |
| EXAS | SELL | 2018-08-30 | $369K | — | Filing → |